Outside Publication

ESG Considerations in Europe and Asia: Social Inclusion - The New Diversity Frontier, European Pharmaceutical Review

July 01, 2022

Partners Lesli Ligorner and Louise Skinner authored an article for European Pharmaceutical Review about environmental, social, and governance issues across Asia and Europe, focusing on social inclusion considerations. They discuss the landscape, employer reporting, and changing regulatory expectation.

Read the full European Pharmaceutical Review article >>

Subscription may be required.